Aprea Therapeutics, Inc. Unrecognized Tax Benefits
Aprea Therapeutics, Inc. (APRE) had Unrecognized Tax Benefits of $0 as of 2020-09-30, per its 10-Q filed 2020-11-06.
Discontinued › Notes › Income Taxes
us-gaap:UnrecognizedTaxBenefits · last filed 2020-11-06
- 2020-09-30: Unrecognized Tax Benefits $0.00.
- 2020-06-30: Unrecognized Tax Benefits $0.00.
- 2020-03-31: Unrecognized Tax Benefits $0.00.
- 2019-12-31: Unrecognized Tax Benefits $0.00.
| Period end | Unrecognized Tax Benefits |
|---|---|
| 2020-09-30 | $0.00 10-Q · filed 2020-11-06 |
| 2020-06-30 | $0.00 10-Q · filed 2020-08-11 |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-15 |
| 2019-12-31 | $0.00 10-Q · filed 2020-11-06 |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-14 |
| 2018-12-31 | $0.00 10-Q · filed 2019-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |